Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 26.90
+0.40 (1.51%)
Jan 28, 2026, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 612.68 million as of January 28, 2026. Its market cap has decreased by -29.33% in one year.
Market Cap
612.68M
Enterprise Value
571.32M
Revenue
90.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.90
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 612.68M, an increase of 984.33%. That is a compound annual growth rate of 17.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 612.68M | -2.21% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 447.83M |
| Bioceltix | 385.59M |
| BIOTON | 345.17M |
| Synthaverse | 283.08M |
| Molecure | 146.28M |
| Mabion | 132.37M |
| Poltreg | 119.85M |
| NanoGroup | 88.64M |